These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11597587)

  • 1. Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys.
    Kakiuchi T; Ohba H; Nishiyama S; Sato K; Harada N; Nakanishi S; Tsukada H
    Brain Res; 2001 Oct; 916(1-2):22-31. PubMed ID: 11597587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys.
    Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Sato K; Harada N; Takahashi K
    Synapse; 2001 Sep; 41(3):248-57. PubMed ID: 11418938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with.
    Tsukada H; Takahashi K; Miura S; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Hatazawa J; Okudera T
    Synapse; 2001 Feb; 39(2):182-92. PubMed ID: 11180506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of muscarinic cholinergic receptor ligands N-[11C]ethyl-4-piperidyl benzilate and N-[11C]propyl-4-piperidyl benzilate: a PET study in comparison with N-[11C]methyl-4-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Sato K; Harada N; Kakiuchi T; Tsukada H
    Nucl Med Biol; 2000 Nov; 27(8):733-40. PubMed ID: 11150704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography.
    Suhara T; Inoue O; Kobayashi K; Suzuki K; Tateno Y
    Neurosci Lett; 1993 Jan; 149(2):225-8. PubMed ID: 8474698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related reduction of [11C]MDL100,907 binding to central 5-HT(2A) receptors: PET study in the conscious monkey brain.
    Kakiuchi T; Nishiyama S; Sato K; Ohba H; Nakanishi S; Tsukada H
    Brain Res; 2000 Nov; 883(1):135-42. PubMed ID: 11063997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding kinetics of 11C-N-methyl piperidyl benzilate (11C-NMPB) in a rhesus monkey brain using the cerebellum as a reference region.
    Itoh T; Tanaka M; Kobayashi K; Suzuki K; Inoue O
    Ann Nucl Med; 2005 Sep; 19(6):499-505. PubMed ID: 16248387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cerebral blood flow and postsynaptic muscarinic cholinergic activity in rats with bilateral carotid artery ligation.
    Ouchi Y; Tsukada H; Kakiuchi T; Nishiyama S; Futatsubashi M
    J Nucl Med; 1998 Jan; 39(1):198-202. PubMed ID: 9443761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and autoradiographic localization of muscarinic cholinergic antagonist (+)N-[11C]methyl-3-piperidyl benzilate as a potent radioligand for positron emission tomography.
    Takahashi K; Murakami M; Miura S; Iida H; Kanno I; Uemura K
    Appl Radiat Isot; 1999 Mar; 50(3):521-5. PubMed ID: 10070712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral muscarinic acetylcholinergic receptor measurement in Alzheimer's disease patients on 11C-N-methyl-4-piperidyl benzilate--comparison with cerebral blood flow and cerebral glucose metabolism.
    Yoshida T; Kuwabara Y; Ichiya Y; Sasaki M; Fukumura T; Ichimiya A; Takita M; Ogomori K; Masuda K
    Ann Nucl Med; 1998 Feb; 12(1):35-42. PubMed ID: 9559960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of reference tissue model of PET ligand [¹¹C]+3-MPB for the muscarinic cholinergic receptor in the living brain of conscious monkey.
    Yamamoto S; Ohba H; Nishiyama S; Takahashi K; Tsukada H
    Synapse; 2011 Jun; 65(6):548-51. PubMed ID: 21064187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.
    Asahina M; Suhara T; Shinotoh H; Inoue O; Suzuki K; Hattori T
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):155-63. PubMed ID: 9703164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aging on 5-HT(1A) receptors and their functional response to 5-HT(1a) agonist in the living brain: PET study with [carbonyl-(11)C]WAY-100635 in conscious monkeys.
    Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Harada N
    Synapse; 2001 Dec; 42(4):242-51. PubMed ID: 11746722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET.
    Zubieta JK; Koeppe RA; Frey KA; Kilbourn MR; Mangner TJ; Foster NL; Kuhl DE
    Synapse; 2001 Mar; 39(4):275-87. PubMed ID: 11169777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.
    Yamamoto S; Nishiyama S; Kawamata M; Ohba H; Wakuda T; Takei N; Tsukada H; Domino EF
    Neuropsychopharmacology; 2011 Jun; 36(7):1455-65. PubMed ID: 21430646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (R)-N-[11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radioligand for PET studies of the muscarinic acetylcholine receptor.
    Skaddan MB; Jewett DM; Sherman PS; Kilbourn MR
    Synapse; 2002 Jul; 45(1):31-7. PubMed ID: 12112411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding.
    Zubieta JK; Koeppe RA; Mulholland GK; Kuhl DE; Frey KA
    J Cereb Blood Flow Metab; 1998 Jun; 18(6):619-31. PubMed ID: 9626186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-related differences in the muscarinic acetylcholinergic receptor in the healthy human brain--a positron emission tomography study.
    Yoshida T; Kuwabara Y; Sasaki M; Fukumura T; Ichimiya A; Takita M; Ogomori K; Ichiya Y; Masuda K
    Ann Nucl Med; 2000 Apr; 14(2):97-101. PubMed ID: 10830526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET).
    Dewey SL; Volkow ND; Logan J; MacGregor RR; Fowler JS; Schlyer DJ; Bendriem B
    J Neurosci Res; 1990 Dec; 27(4):569-75. PubMed ID: 2079718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.